Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Siegall, William B.
20  Ergebnisse:
Personensuche X
?
1

An important consideration when expressing mAbs in Escheric..:

Siegall, William B. ; Lyon, Rachel B. ; Kelman, Zvi
Protein Expression and Purification.  220 (2024)  - p. 106499 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Contributions from ClpS surface residues in modulating N-te..:

Callahan, Nicholas ; Siegall, William B ; Bergonzo, Christina..
Protein Engineering, Design and Selection.  36 (2023)  - p. , 2023
Link: https://doi.org/10.1093/..
 
?
3

A two‐antibody model for copper‐64 radioimmunotherapy: biod..:

Bryan, J. N. ; Mohsin, H. ; Jia, F....
Veterinary and Comparative Oncology.  2 (2004)  2 - p. 99-99 , 2004
Link: https://doi.org/10.1111/..
 
?
4

Erratum: Development of potent monoclonal antibody auristat..:

Doronina, Svetlana O ; Toki, Brian E ; Torgov, Michael Y...
Nature Biotechnology.  21 (2003)  8 - p. 941-941 , 2003
Link: https://doi.org/10.1038/..
 
?
5

Development of potent monoclonal antibody auristatin conjug..:

Doronina, Svetlana O ; Toki, Brian E ; Torgov, Michael Y...
Nature Biotechnology.  21 (2003)  7 - p. 778-784 , 2003
Link: https://doi.org/10.1038/..
 
?
6

Selective tumor sensitization to taxanes with the mAb-drug ..:

Wahl, Alan F. ; Donaldson, Karen L. ; Mixan, Bruce J...
International Journal of Cancer.  93 (2001)  4 - p. 590-600 , 2001
Link: https://doi.org/10.1002/..
 
?
7

Identification of a specific tyrosine residue in Bryodin 1 ..:

Fryxell, Daniel K. ; Gawlak, Susan L. ; Dodge, Robert W..
Protein Science.  7 (1998)  2 - p. 318-324 , 1998
Link: https://doi.org/10.1002/..
 
?
8

Expression and Characterization of Bryodin 1 and a Bryodin ..:

Francisco, Joseph A. ; Gawlak, Susan L. ; Miller, Michael...
Bioconjugate Chemistry.  8 (1997)  5 - p. 708-713 , 1997
Link: https://doi.org/10.1021/..
 
?
9

Molecular, Biological, and Preliminary Structural Analysis ..:

Gawlak, Susan L. ; Neubauer, Michael ; Klei, Herbert E....
Biochemistry.  36 (1997)  11 - p. 3095-3103 , 1997
Link: https://doi.org/10.1021/..
 
?
10

Construction, Expression, and Characterization of BD1-G28-5..:

Francisco, Joseph A. ; Gawlak, Susan L. ; Siegall, Clay B.
Journal of Biological Chemistry.  272 (1997)  39 - p. 24165-24169 , 1997
Link: https://doi.org/10.1074/..
 
?
11

HER4 Expression Correlates with Cytotoxicity Directed by a ..:

Bacus, Sarah S. ; Chin, Dot M. ; Goetze, Andy...
Journal of Biological Chemistry.  270 (1995)  13 - p. 7625-7630 , 1995
Link: https://doi.org/10.1074/..
 
?
12

Immunotoxins as cancer chemotherapeutic agents:

Siegall, Clay B. ; Wolff, Edith A. ; Gawlak, Susan L....
Drug Development Research.  34 (1995)  2 - p. 210-219 , 1995
Link: https://doi.org/10.1002/..
 
?
13

TGFα-PE40 inhibits non-small cell lung cancer growth:

Draoui, Muriel ; Siegall, Clay B. ; FitzGerald, David..
Life Sciences.  54 (1994)  7 - p. 445-453 , 1994
Link: https://doi.org/10.1016/..
 
?
14

Prevention of immunotoxin-mediated vascular leak syndrome i..:

Siegall, C B ; Liggitt, D ; Chace, D..
Proceedings of the National Academy of Sciences.  91 (1994)  20 - p. 9514-9518 , 1994
Link: https://doi.org/10.1073/..
 
?
15

Prevention of Immunotoxin-Mediated Vascular Leak Syndrome i..:

Siegall, Clay B. ; Liggitt, Denny ; Chace, Dana..
Proceedings of the National Academy of Sciences of the United States of America.  91 (1994)  20 - p. 9514-9518 , 1994
Link: https://www.jstor.org/st..
 
1-15